Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 740 of 1,261

  1. US 9097713

    Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  2. US 9096625

    BCL-2/BCL-XL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  3. US 9097707

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  4. US 9096496

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  5. US 9095558

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  6. US 9095593

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  7. US 9096830

    Multi-layered hydrogel constructs and associated methods

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  8. US 9096517

    Oligomer-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  9. US 9096679

    Peptide compounds and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  10. US 9096653

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  11. US 9096689

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  12. US 9096647

    Simplified one-pot synthesis of [18F]SFB for radiolabeling

    The Regents of the University of California · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  13. US 9096637

    Organic compositions to treat HSF1-related diseases

    Arrowhead Research Corporation · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  14. US 9096642

    Therapeutic compounds for immunomodulation

    Aurigene Discovery Technologies Limited · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  15. US 9096609

    Macrocyclic LRRK2 kinase inhibitors

    Oncodesign SA · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  16. US 9096608

    Pharmaceutically active pyrazolo-triazine derivatives

    Lead Discovery Center GmbH · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  17. US 9096602

    Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  18. US 9096584

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  19. US 9096543

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  20. US 9096515

    Methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  21. US 9096499

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  22. US 9096501

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  23. US 9095624

    Modular transport platform for targeted delivery of therapeutic agents

    Contango Partners Group, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  24. US 9095629

    Magnetic nanostructures as theranostic agents

    Northwestern University · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.